1MEDICATION LIST

DO NOT TYPE IN SHADED AREAS. Hit the tab key in the bottom row, right hand column to add more rows as needed Medication Dose Route Frequency Pharm Classification
Stool softener

Indications for use for assigned patient and pertinent nursing implications specific to this drug
I: constipation C: diarrhea, fecal impaction, mineral oil use, appendicitis, acute abd, GI obstruction SE: diarrhea, abd cramping, throat irritation, rash, electrolyte disorder, bitter taste NI: check for impaction, assess abd, check GI history, assess possible cause of constipation, monitor BMs, d/c with loose stools; check electrolytes

Docusate Sodium (Colace)

50mg, 100mg capsule, liquid, syrup

Oral

50mg-300mg daily, using daily to qid dosing

Digoxin (Lanoxin)

.125mg, . 25mg, .5mg

IV, IM

qd, bid, qid dosing

Inotropes/Pressors; cardiac glycoside

I: CHF, atrial fibrillation, atrial flutter, PSVT; C: allergy, ventricular fibrillation, ventricular tachycardia, IHSS, AV accessory pathway, Sick Sinus Syndrome, caution with bradycardia, AV block, acute myopathy, etc; SE: AV block, severe bradycardia, ventricular arrhythmia, thrombocytopenia, delirium, hallucinations, HA, dizziness, diarrhea, N/V, anorexia, weakness, palpitations, tachycardia, confusion, depression, ventricular ectopy, gynecomastia, rash; NI: monitor heart rate, monitor heart rhythm, monitor BM, monitor mental status, monitor drug levels, monitor electrolytes and renal function

Atropine

.4mg, .5mg, . 6mg, 1mg, 1.2mg, 2mg

SC, IM, IV, INJ

Q3-5 minutes, Antiarrhythmics q4-6hrs,

I: Asystole/PEA, bradycardia, anesthesia adjunct, neuromuscular blockade reversal adjunct, organophosphate poisoning, nerve agent poisoning;

Medication

Dose

Route

Frequency

Pharm Classification

Indications for use for assigned patient and pertinent nursing implications specific to this drug
C: allergy, glaucoma, obstructive uropathy, paralytic ileus, toxic megacolon, asthma, myasthenia gravis, caution in the elderly, with Down Syndrome and brain damage; SE: severe bradycardia, anaphylaxis, HA, dry mouth, nausea, insomnia, dizziness, restlessness, blurred vision, mydriasis, constipation, delirium, tachycardia, palpitations, ataxia, tremor, dry hot skin; NI: assess PMH, assess heart rate, assess heart rhythm, assess bowels, assess mental status, assess motor skills

Diltiazem (Cardizem)

30, 60, 90, 120, 180, 240, 300, 360, 420mg regular and extended release

PO, IV

Qd, bid, qid

Antiarrhythmic; calcium channel blocker

I: angina, HTN, atrial fibrillation/flutter, PSVT conversion; C: Sick Sinus Syndrome, 2nd or 3rd degree AV block, severe hypotension, cardiogenic shock, atrial fibrillation/flutter associated with WPW syndrome, short PR syndrome, ventricular tachycardia, concomitant IV Beta blockers; SE: hypotension, vasodilation, arrhythmia, hepatotoxicity, PVCs, local dermatological reaction; NI: monitor cardiac rhythm, monitor B/P, monitor liver function, monitor skin

Metformin (Glucophage)

500, 850, 1000mg

PO

Qd, bid

Biguanide

I: DMII; C: renal disease/insufficiency, metabolic acidosis, DKA, hold for 48hrs after IVP dye; SE: GI disturbances, taste disturbance (transient), lactic acidosis; NI: monitor glucose levels, monitor renal function, monitor GI s/s, monitor lactic acid levels,

Avelox (Moxifloxacin)

400mg

PO, IV

qd

Quinolone

I: sinusitis, chronic bronchitis, community acquired pneumonia, intra-abdominal infections C: allergy, prolonged QT interval, hypokalemia,

Medication

Dose

Route

Frequency

Pharm Classification

Indications for use for assigned patient and pertinent nursing implications specific to this drug
proarrhythmic condition, caution in pts with seizure disorder, kidney/heart/lung transplant, CNS disorder, dehydration, liver dysfunction, tendonitis SE: allergy, anaphylaxis, tendon rupture, phototoxicity, pseudomembranous colitis, superinfection, increased ICP, seizures, toxic psychosis, depression, suicidal ideation, skin reaction, vasculitis, serum sickness, nephrotoxicity, hepatotoxicity, prolonged QT interval, torsades de pointes, peripheral neuropathy, arthropathy, nausea, diarrhea, dizziness NI: monitor for allergic reaction, monitor for myalgia, monitor for neuro changes, monitor liver and renal function, monitor cardiac rhythm

Actos (Pioglitazone)

15, 30, 45mg

PO

qd

thiazolidinedione

I: DMII C: allergy, type I DM, DKA, CHF, ALT >2.5, caution with CHF, edema, hepatic dysfunction, insulin use, caution in female pts, may induce ovulation SE: CHF, hepatotoxicity, DM macular edema, bladder CA, fractures in female pts, fluid retention, edema, weight gain, URI, HA, sinusitis, myalgia, pharyngitis, dyspnea, anemia, hypoglycemia NI: monitor for allergy, monitor blood glucose, monitor liver function, monitor electrolytes, monitor for edema, monitor cardiac function, monitor lung sounds, monitor weight

Tigan (Trimethobenzamide)

300mg

IM, PO

Tid, qid

Antinausea, antiemetic

I: nausea/vomiting C: allergy, infants/peds, caution with dehydration, electrolyte imbalance, and

Medication

Dose

Route

Frequency

Pharm Classification

Indications for use for assigned patient and pertinent nursing implications specific to this drug elderly/debilitated pts SE: allergy, coma, seizures, extrapyramidal symptoms, hypotension, blood dyscrasias, opisthotonus, cholestasis, blurred vision, depression, HA, drowsiness, muscle cramps, disorientation, jaundice, local pain/irritation NI: monitor for allergic reaction, monitor for change in neuro function, monitor B/P